Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

Author(s):: Wong, D.R.; Coenen, M.J.H.; Vermeulen, S.H.; Derijks, L.J.J.; Marrewijk, C.J. van; Klungel, O.H.; Scheffer, H.; Franke, B.; Guchelaar, H.J. (0000-0002-7085-1383); Jong, D.J. de; Engels, L.G.J.B.; Verbeek, A.L.M.; Hooymans, P.M.

Published: 2017
Publication type: Article / Letter to editor

Thiopurinestoxicityinflammatory bowel disease

Date issued: 2017-02-28
Language: English
Is part of: Journal of Crohn's and Colitis (2017), Vol. 11, no. 2, p. 175-184
hdl: 1887/114720
doi: 10.1093/ecco-jcc/jjw130